Cargando…
Diffusion tensor imaging changes in patients with glioma-associated seizures
INTRODUCTION: Structural white matter changes associated with certain epilepsy subtypes have been demonstrated using diffusion tensor imaging (DTI). This observational study aims to identify potential water diffusion abnormalities in glioma patients with associated seizures. METHODS: Two cohorts fro...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722813/ https://www.ncbi.nlm.nih.gov/pubmed/36344852 http://dx.doi.org/10.1007/s11060-022-04139-9 |
_version_ | 1784844039329153024 |
---|---|
author | Mader, Marius Marc-Daniel Deuter, Daniel Sauvigny, Thomas Borchert, Patrick Faizy, Tobias D. Bester, Maxim Westphal, Manfred Rosengarth, Katharina Schmidt, Nils O. Sedlacik, Jan Dührsen, Lasse |
author_facet | Mader, Marius Marc-Daniel Deuter, Daniel Sauvigny, Thomas Borchert, Patrick Faizy, Tobias D. Bester, Maxim Westphal, Manfred Rosengarth, Katharina Schmidt, Nils O. Sedlacik, Jan Dührsen, Lasse |
author_sort | Mader, Marius Marc-Daniel |
collection | PubMed |
description | INTRODUCTION: Structural white matter changes associated with certain epilepsy subtypes have been demonstrated using diffusion tensor imaging (DTI). This observational study aims to identify potential water diffusion abnormalities in glioma patients with associated seizures. METHODS: Two cohorts from two centers were analyzed independently: (A) Prospectively recruited patients diagnosed with glioma who received preoperative DTI to measure mean diffusivity (MD) and fractional anisotropy (FA) in regions-of-interest (ROIs) including the marginal tumor zone (TU), adjacent peritumoral white matter as well as distant ipsilateral and contralateral white matter and cortex. Data were compared between patients with and without seizures and tested for statistical significance. (B) A retrospective cohort using an alternative technical approach sampling ROIs in contrast enhancement, necrosis, non-enhancing tumor, marginal non-enhancing tumor zone, peritumoral tissue, edema and non-tumorous tissue. RESULTS: (A) The prospective study cohort consisted of 23 patients with 12 (52.2%) presenting with a history of seizures. There were no significant seizure-associated differences in MD or FA for non-tumor white matter or cortical areas. MD-TU was significantly lower in patients with seizures (p = 0.005). (B) In the retrospective cohort consisting of 46 patients with a seizure incidence of 50.0%, significantly decreased normalized values of MD were observed for non-enhancing tumor regions of non-glioblastoma multiforme (GBM) cases in patients with seizures (p = 0.022). CONCLUSION: DTI analyses in glioma patients demonstrated seizure-associated diffusion restrictions in certain tumor-related areas. No other structural abnormalities in adjacent or distant white matter or cortical regions were detected. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-022-04139-9. |
format | Online Article Text |
id | pubmed-9722813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-97228132022-12-07 Diffusion tensor imaging changes in patients with glioma-associated seizures Mader, Marius Marc-Daniel Deuter, Daniel Sauvigny, Thomas Borchert, Patrick Faizy, Tobias D. Bester, Maxim Westphal, Manfred Rosengarth, Katharina Schmidt, Nils O. Sedlacik, Jan Dührsen, Lasse J Neurooncol Case Study INTRODUCTION: Structural white matter changes associated with certain epilepsy subtypes have been demonstrated using diffusion tensor imaging (DTI). This observational study aims to identify potential water diffusion abnormalities in glioma patients with associated seizures. METHODS: Two cohorts from two centers were analyzed independently: (A) Prospectively recruited patients diagnosed with glioma who received preoperative DTI to measure mean diffusivity (MD) and fractional anisotropy (FA) in regions-of-interest (ROIs) including the marginal tumor zone (TU), adjacent peritumoral white matter as well as distant ipsilateral and contralateral white matter and cortex. Data were compared between patients with and without seizures and tested for statistical significance. (B) A retrospective cohort using an alternative technical approach sampling ROIs in contrast enhancement, necrosis, non-enhancing tumor, marginal non-enhancing tumor zone, peritumoral tissue, edema and non-tumorous tissue. RESULTS: (A) The prospective study cohort consisted of 23 patients with 12 (52.2%) presenting with a history of seizures. There were no significant seizure-associated differences in MD or FA for non-tumor white matter or cortical areas. MD-TU was significantly lower in patients with seizures (p = 0.005). (B) In the retrospective cohort consisting of 46 patients with a seizure incidence of 50.0%, significantly decreased normalized values of MD were observed for non-enhancing tumor regions of non-glioblastoma multiforme (GBM) cases in patients with seizures (p = 0.022). CONCLUSION: DTI analyses in glioma patients demonstrated seizure-associated diffusion restrictions in certain tumor-related areas. No other structural abnormalities in adjacent or distant white matter or cortical regions were detected. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-022-04139-9. Springer US 2022-11-07 2022 /pmc/articles/PMC9722813/ /pubmed/36344852 http://dx.doi.org/10.1007/s11060-022-04139-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Case Study Mader, Marius Marc-Daniel Deuter, Daniel Sauvigny, Thomas Borchert, Patrick Faizy, Tobias D. Bester, Maxim Westphal, Manfred Rosengarth, Katharina Schmidt, Nils O. Sedlacik, Jan Dührsen, Lasse Diffusion tensor imaging changes in patients with glioma-associated seizures |
title | Diffusion tensor imaging changes in patients with glioma-associated seizures |
title_full | Diffusion tensor imaging changes in patients with glioma-associated seizures |
title_fullStr | Diffusion tensor imaging changes in patients with glioma-associated seizures |
title_full_unstemmed | Diffusion tensor imaging changes in patients with glioma-associated seizures |
title_short | Diffusion tensor imaging changes in patients with glioma-associated seizures |
title_sort | diffusion tensor imaging changes in patients with glioma-associated seizures |
topic | Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722813/ https://www.ncbi.nlm.nih.gov/pubmed/36344852 http://dx.doi.org/10.1007/s11060-022-04139-9 |
work_keys_str_mv | AT madermariusmarcdaniel diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT deuterdaniel diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT sauvignythomas diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT borchertpatrick diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT faizytobiasd diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT bestermaxim diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT westphalmanfred diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT rosengarthkatharina diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT schmidtnilso diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT sedlacikjan diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures AT duhrsenlasse diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures |